What is DIH Holdings US, Inc. Class A Common Stock?
provides advanced robotic devices used in physical rehabilitation in Europe, the Middle East, Africa, the United States, and the Asia Pacific.
DHAI · Verdict
Moderate reward · elevated risk
DHAI stands out on volatility and valuation, but watch the balance sheet signal.
Based on 88% data coverage
DHAI · Verdict
Above average
Above average
Current ratio 0.49
-7% free-cash-flow margin
-14% net margin · 0% ROE
Rev +4.6% CAGR · earnings +54.3%
Model-based scoring. For information only — not financial advice.
provides advanced robotic devices used in physical rehabilitation in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 5.23K.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.